Medtronic received information that two years and 8 months post implant of stentless bioprosthetic heart, patient was admitted for an apparent cerebrovascular accident.It was noted that the patient had elevated troponin levels and diagnosed with a myocardial infarction.Patient's heart rate was in the thirties and a permanent pacemaker was implanted during hospitalization.No additional adverse patient effects were reported.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|